CD33-directed Antibody Interactions [MoA] - N0000175077

Pharmacologic Class Information

Pharmacologic Code N0000175077
Pharmacologic Name CD33-directed Antibody Interactions
Pharmacologic Uses
  • CD33-directed antibody-drug conjugate
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with CD33-directed Antibody Interactions

The following table contains 1 products whose active ingredient are classified under the same pharmacologic class CD33-directed Antibody Interactions [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0008-4510Mylotarg Non-Proprietary Name: Gemtuzumab OzogamicinInjection, Powder, Lyophilized, For SolutionIntravenousWyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.ACTIVE